XENO
XENO TRANSPLANTS CORP by Xeno Transplants Corp. (XENO)
$00
About XENO TRANSPLANTS CORP by Xeno Transplants Corp. (XENO)
Xeno Transplants Corp. operates as a bio-technology research and development company. It intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources. The company was founded on October 5, 2004 and is headquartered in Vancouver, Canada.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
4,000
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
--
XENO TRANSPLANTS CORP by Xeno Transplants Corp. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
4,000
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
--